AU6734598A - Thiazolobenzoheterocycles, preparation and medicines containing same - Google Patents

Thiazolobenzoheterocycles, preparation and medicines containing same

Info

Publication number
AU6734598A
AU6734598A AU67345/98A AU6734598A AU6734598A AU 6734598 A AU6734598 A AU 6734598A AU 67345/98 A AU67345/98 A AU 67345/98A AU 6734598 A AU6734598 A AU 6734598A AU 6734598 A AU6734598 A AU 6734598A
Authority
AU
Australia
Prior art keywords
alkyl
alk
ch2oh
preparation
nr11r12
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67345/98A
Inventor
Jean-Claude Aloup
Jean Bouquerel
Jean-Claude Hardy
Serge Mignani
Patrick Nemecek
Jean-Francois Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU6734598A publication Critical patent/AU6734598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The invention concerns compounds of formula (I) in which R1 represents a sulphur or selenium atom, R2 represents hydrogen or alkyl, -R3-R4-R5- represents a chain of formula -CH2-CH2-CH2-, -CH(R7)-CH2-CH2-, -CH2-CH2-CH(R8)-, -CH2-CH(R9)-CH2-, -CH2-CH2-S-, -CH2-CH2-SO-, -CH2-CH2-SO2-, -CH2-CH2-Se-, -CH2-CH2-O-, -CH2-CH2-CO-, -CH2-CH2-N(R10)-, -CH2-CO-N(R10)-, -CH2-CF2-CH2-, -CH2-CF2-CH(OH)-, -CH2-CH(R13)-S-, -CH2-CH(R13)-SO-, or -CH2-CH(R13)-SO2-, R6 represents a polyfluoroalkyl, polyfluoroalcoxy or polyfluoroalkylthio radical, R7 represents alkyl, -CH2OH, -CH2-SO2-alk or -CH2-NR11R12, R8 represents alkyl, hydroxy, -CH2OH, -NR11R12, -CH2-NR11R12, -S-alk, -SO-alk, -SO2-alk, thienyl, furyl, phenyl, or phenyl substituted, R9 represents alkyl or -CH2OH, R10 represents hydrogen or alkyl, R11 represents hydrogen or alkyl, -CO-alk or -CO-CF3, R12 represents hydrogen or alkyl, or R11 and R12 form with the nitrogen atom to which they are bound a heterocyclic compound, R13 represents alkyl or -CH2OH, their salts, their methods of preparation, medicines containing them and the intermediates.
AU67345/98A 1997-02-28 1998-02-26 Thiazolobenzoheterocycles, preparation and medicines containing same Abandoned AU6734598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9702436 1997-02-28
FR9702436A FR2760237B1 (en) 1997-02-28 1997-02-28 THIAZOLOBENZOHETEROCYCLES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM
PCT/FR1998/000376 WO1998038194A1 (en) 1997-02-28 1998-02-26 Thiazolobenzoheterocycles, preparation and medicines containing same

Publications (1)

Publication Number Publication Date
AU6734598A true AU6734598A (en) 1998-09-18

Family

ID=9504307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67345/98A Abandoned AU6734598A (en) 1997-02-28 1998-02-26 Thiazolobenzoheterocycles, preparation and medicines containing same

Country Status (10)

Country Link
EP (1) EP0966473B1 (en)
JP (1) JP4436460B2 (en)
AT (1) ATE221075T1 (en)
AU (1) AU6734598A (en)
DE (1) DE69806734T2 (en)
DK (1) DK0966473T3 (en)
ES (1) ES2180156T3 (en)
FR (1) FR2760237B1 (en)
PT (1) PT966473E (en)
WO (1) WO1998038194A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA90269C2 (en) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Tetrahydroquinoline derivatives and a process for preparing the same
DE102005027168A1 (en) * 2005-06-13 2006-12-14 Merck Patent Gmbh Tetrahydroquinolines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
JPS55111406A (en) * 1979-02-19 1980-08-28 Takeda Chem Ind Ltd Agent for controlling plant disease
DK160941C (en) * 1988-06-28 1991-10-21 Novo Nordisk As CONDENSED 2,3-DIHYDROXYPYRAZINES, THEIR PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE COMPOUNDS
KR0167346B1 (en) * 1989-06-09 1999-01-15 로버트 에이. 아미테이지 Heterocyclic amines having central nervous system activity
ATE205837T1 (en) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh CHINOXALINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
EP0705835A1 (en) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Quinoxalic-2,3-diones with an oxa or thiaheterocyclic fused ring

Also Published As

Publication number Publication date
DE69806734T2 (en) 2002-12-05
DK0966473T3 (en) 2002-11-18
WO1998038194A1 (en) 1998-09-03
EP0966473B1 (en) 2002-07-24
JP4436460B2 (en) 2010-03-24
EP0966473A1 (en) 1999-12-29
ES2180156T3 (en) 2003-02-01
FR2760237B1 (en) 1999-04-16
JP2001517214A (en) 2001-10-02
ATE221075T1 (en) 2002-08-15
PT966473E (en) 2002-12-31
DE69806734D1 (en) 2002-08-29
FR2760237A1 (en) 1998-09-04

Similar Documents

Publication Publication Date Title
TR200402656T4 (en) Thiophene derivatives useful as anticancer agents
ES2173683T3 (en) SUPEROXIDE RADICAL INHIBITOR.
HK1092872A1 (en) Modulating the interaction between hgf beta chain and c-met
DK1171084T3 (en) Zinc-containing toothpaste compositions
HK1079522A1 (en) Thienyl compounds
ES2422383T3 (en) Urea glucokinase activators
BR9510529A (en) Formulations and methods for reducing skin irritation
AU3680501A (en) Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
HRP20010117B1 (en) Novel salt form of pantoprazole
BR0109991A (en) Pharmaceutical Composition
EP1072608A4 (en) Glutathione derivatives and dosage forms thereof
MXPA05013751A (en) Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof.
DE60019121D1 (en) KALIUMKANÄLEÖFFNER
DK0947504T3 (en) 16-vitamin D derivatives
AU6734598A (en) Thiazolobenzoheterocycles, preparation and medicines containing same
NZ503710A (en) 2-Substituted- 4'-hydroxy-5,9,9-trimethyl-6,7-benzomorphan derivatives useful in treating vascular diseases
DK0842165T3 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
CO5580729A2 (en) NUTRITIONAL COMPOSITIONS THAT INCLUDE CISTATIONINE
BRPI0400787A (en) Microbicidal composition
CA1268469C (en) Photoactive bithienyl pesticides
AP2000002008A0 (en) Tetrahydroquinoline derivatives as glycine antagonists.
BR0104353A (en) Taxanes heterosubstituted with c7 acetate as antitumor agents
DE60001366D1 (en) ORAL COMPOSITION CONTAINING PERLITE
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
BG105966A (en) C7 carbonate substituted taxanes and their application as antitumor agents